Nuveen
TLSI icon

Nuveen’s TriSalus Life Sciences TLSI Stock Holding History

Nuveen’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$288K Buy
66,896
+2,998
+5% +$14.2K ﹤0.01% 3654
2026
Q2 		$291K Buy
63,898
+27,348
+75% +$109K ﹤0.01% 3513
2026
Q1 		$146K Hold
36,550
– – ﹤0.01% 3149
2025
Q4 		$255K Buy
36,550
+15,956
+77% +$89.3K ﹤0.01% 3087
2025
Q3 		$95.8K Hold
20,594
– – ﹤0.01% 3225
2025
Q2 		$112K Buy
+20,594
New +$110K ﹤0.01% 3242

Other funds holding TLSI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Thompson Siegel & Walmsley
Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return
White Pine Capital
White Pine Capital Bloomington, Minnesota $419M AUM 48.71% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Nuveen's TLSI Position: Q3 2026 in Review

Nuveen increased its TriSalus Life Sciences (TLSI) stake by 4.7% in Q3 2026, buying an estimated $14.2K and bringing the position to 66,896 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #3654.

Nuveen first reported a position in TLSI in Q2 2025 and has held it in 6 quarters since. The position peaked at $291K in Q2 2026. 39 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

  • Nuveen held 66,896 shares of TriSalus Life Sciences worth $288K as of Q3 2026.
  • Nuveen bought 2,998 TriSalus Life Sciences shares in Q3 2026, an estimated $14.2K.
  • TriSalus Life Sciences made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #3654 holding.
  • Nuveen first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 6 quarters since.
  • Nuveen's TriSalus Life Sciences position peaked at $291K in Q2 2026.
  • 39 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.